Sell v. Brantner
Opinion of the Court
And now, to wit, June 10,2003, following a hearing on May 30,2003 and subsequent review of evidence submitted by the parties following the hearing, this arbitrator makes the following finding and enters the following award:
FINDINGS
This arbitrator finds that the claimant, Pamela Sell, was not advised by Dr. James Brantner of the risk of rupture of her breast implants prior to breast augmentation surgery on May 26,1989. This arbitrator accepts as credible the testimony of Pamela Sell, to the effect that she was not advised as to the risk of future potential rupture and believed that the implants would last her lifetime. Ms. Sell testified credibly that, since this was elective, voluntary surgery, she would have opted against breast implant surgery if she knew or was warned that there was a risk of rupture with attendant surgery to remove ruptured implants. If she had been provided with this information, the claimant forcefully testified that she would have not undergone the procedure.
Dr. Brantner offered detailed testimony concerning the risk of breast augmentation surgery in general as well as the specific risks he conveyed to the claimant. He may have indicated a risk of future surgery if claimant developed capsular contracture, but Dr. Brantner did not testify affirmatively and convincingly that he directly warned Pamela Sell as to the risk of rupture with attendant surgery. Beyond Dr. Brantner’s testimony, the “permission for operation” form sets forth certain general risks of breast augmentation surgery, including the risk
Defendant’s expert witness, Dr. Charles E. Pappas, addresses in his report the A.S.P.R.S. booklet and states that in this booklet “that Ms. Sell was exposed to all of the material risks of breast augmentation that were known to us and which were identified and explained, including but not limited to . . . implant rupture.” To this arbitrator’s review, the A.S.P.R.S. booklet submitted fails
For these reasons, this arbitrator finds that the risk of rupture, although perhaps not the primary risk of breast augmentation surgery, was a known and recognized risk of the procedure which constituted a “material risk” and one which a reasonable and prudent person would have wanted to know of and would have considered material to her decision whether to undergo breast augmentation surgery. This arbitrator finds that Pamela Sell would have considered knowledge of the risk of rupture significant in making her decision and that claimant was not provided with this material risk information.
In regards to damages, this arbitrator recognizes that the claimant had to undergo a surgical procedure for ex-plantation of the implants under general anesthesia. During the surgical procedure, Dr. Lu-Jean Feng’s records reveal that it was necessary to remove the implants from a different surgical site than the one into which they were inserted, resulting in new incisions made in the infra-mammary folds. Although the claimant presumably has
AWARD
I, the undersigned arbitrator, Harry M. Paras, Esquire, having been duly appointed by the court and sworn make the following award:
The arbitrator enters an award in favor of the claimant, Pamela C. Sell and against the defendant, James N. Brantner M.D., in the amount of $40,000.
Case-law data current through December 31, 2025. Source: CourtListener bulk data.